Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides

FOXO4-DRI

Other
Preclinical Research
15%
Moderate Risk
3/5

Warnings

Experimental senolytic - very limited human data
May impair wound healing
Clears senescent cells - unpredictable effects
Do not use during acute illness or healing

Contraindications

PregnancyBreastfeedingActive CancerWound HealingRecent Surgery

Drug Interactions

ChemotherapyImmunosuppressants

Possible Side Effects

FatigueFlu Like SymptomsInflammation

Legal & Regulatory

FDA Status Research Only
WADA Status Not Prohibited
Prescription Not Required

Pregnancy

Category X - Contraindicated